rs10179686
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_030923.5(TMEM163):c.810-223G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0701 in 151,990 control chromosomes in the GnomAD database, including 577 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.070 ( 577 hom., cov: 32)
Consequence
TMEM163
NM_030923.5 intron
NM_030923.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.123
Publications
7 publications found
Genes affected
TMEM163 (HGNC:25380): (transmembrane protein 163) Predicted to enable zinc ion binding activity. Predicted to be involved in zinc ion import into synaptic vesicle. Predicted to be located in early endosome membrane. Predicted to be active in intracellular vesicle and plasma membrane. Predicted to be integral component of synaptic vesicle membrane. [provided by Alliance of Genome Resources, Apr 2022]
TMEM163 Gene-Disease associations (from GenCC):
- leukodystrophy, hypomyelinating, 25Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.24 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TMEM163 | ENST00000281924.6 | c.810-223G>A | intron_variant | Intron 7 of 7 | 1 | NM_030923.5 | ENSP00000281924.6 | |||
| TMEM163 | ENST00000467316.1 | n.1244-223G>A | intron_variant | Intron 1 of 1 | 2 | |||||
| TMEM163 | ENST00000476823.1 | n.4066-223G>A | intron_variant | Intron 2 of 2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0701 AC: 10642AN: 151870Hom.: 570 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
10642
AN:
151870
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0701 AC: 10660AN: 151990Hom.: 577 Cov.: 32 AF XY: 0.0720 AC XY: 5348AN XY: 74252 show subpopulations
GnomAD4 genome
AF:
AC:
10660
AN:
151990
Hom.:
Cov.:
32
AF XY:
AC XY:
5348
AN XY:
74252
show subpopulations
African (AFR)
AF:
AC:
4234
AN:
41444
American (AMR)
AF:
AC:
1043
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
401
AN:
3470
East Asian (EAS)
AF:
AC:
1300
AN:
5168
South Asian (SAS)
AF:
AC:
413
AN:
4802
European-Finnish (FIN)
AF:
AC:
501
AN:
10566
Middle Eastern (MID)
AF:
AC:
47
AN:
292
European-Non Finnish (NFE)
AF:
AC:
2533
AN:
67944
Other (OTH)
AF:
AC:
188
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
475
950
1425
1900
2375
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
122
244
366
488
610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
539
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.